General Statement of Disclosure:
OWNERSHIP/PARTNERSHIP/PRINCIPAL: SafeBeat Rx: startup company (preclinical research submitted to NIH. $0 non-public equity)(NONE)
OWNERSHIP/PARTNERSHIP/PRINCIPAL: SafeBeat Rx: startup company (preclinical research submitted to NIH. $0 non-public equity)(NONE)